← Leaderboards
Maria Irene Kontaridis
Beth Israel Deaconess Medical Center
$7,712,326
Attributed
$7,712,326
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $839K · FY2007–21$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,712,326 · 4
By mechanism
R01$6,833,296 · 2
R00$702,990 · 1
K99$176,040 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingSignal TransductionHeartPathogenesisBiochemicalCardiacIn VivoMolecularHeart DiseasesSignal PathwayPathway InteractionsProtein Tyrosine PhosphataseGenesCardiac MyocytesRegulationCellsIn VitroMyocardialGeneticFunctional DisorderCongenital Heart DefectsCongenital Heart DisorderHypertrophic CardiomyopathyLoss Of Function Mutation
Grant awards (18)
Role of RhoA in the Molecular Pathogenesis of Heart Disease.$753,797
R01 · FY2021 · HL · contact PI
Role of RhoA in the Molecular Pathogenesis of Heart Disease.$797,343
R01 · FY2020 · HL · contact PI
Role of RhoA in the Molecular Pathogenesis of Heart Disease.$763,525
R01 · FY2019 · HL · contact PI
Role of RhoA in the Molecular Pathogenesis of Heart Disease$704,922
R01 · FY2018 · HL · contact PI
Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart$425,510
R01 · FY2016 · HL · contact PI
Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart$419,126
R01 · FY2015 · HL · contact PI
The Role of RhoA in the Molecular Pathogenesis of Heart Disease$422,037
R01 · FY2014 · HL · contact PI
Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart$417,000
R01 · FY2014 · HL · contact PI
Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart$423,586
R01 · FY2013 · HL · contact PI
The Role of RhoA in the Molecular Pathogenesis of Heart Disease$409,979
R01 · FY2013 · HL · contact PI
The Role of RhoA in the Molecular Pathogenesis of Heart Disease$430,650
R01 · FY2012 · HL · contact PI
The Role of RhoA in the Molecular Pathogenesis of Heart Disease$435,000
R01 · FY2011 · HL · contact PI
The Role of RhoA in the Molecular Pathogenesis of Heart Disease$430,821
R01 · FY2010 · HL · contact PI
Molecular Pathogenesis of the Cardiomyogenic Defects in LEOPARD Syndrome$249,000
R00 · FY2010 · HL · contact PI
Molecular Pathogenesis of the Cardiomyogenic Defects in LEOPARD Syndrome$249,000
R00 · FY2009 · HL · contact PI
Molecular Pathogenesis of the Cardiomyogenic Defects in LEOPARD Syndrome$204,990
R00 · FY2008 · HL · contact PI
Molecular Pathogenesis of the Cardiomyogenic Defects in LEOPARD Syndrome$88,020
K99 · FY2008 · HL · contact PI
Molecular Pathogenesis of the Cardiomyogenic Defects in LEOPARD Syndrome$88,020
K99 · FY2007 · HL · contact PI